NRIX — Nurix Therapeutics, Inc. stock price, charts and financials

QT64Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
24.69
+1.47+6.33%
OverviewShort InterestFilings
NRIXQT64Nurix Therapeutics, Inc.·NASDAQ
24.69+6.33%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20264Statement of changes in beneficial ownership
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20264Statement of changes in beneficial ownership
Jul 09, 20268-KCurrent report
Jul 09, 202610-QQuarterly report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
Jun 08, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 06, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 412
Page
▼
/ 17